Jian Yan

Dr. Yan joined Geneos to lead the research team and brings with her over 15 years of experience in leading preclinical research programs for the development of novel immunotherapies. Prior to joining Geneos, she served as the Vice President of Design and Product Development at NEUVOGEN, where she was responsible for design and development of next generation of therapeutic whole cell cancer vaccines. Prior to NEUVOGEN, Jian was a Director of Antigen Design and Discovery, where she led a cross-functional team to provide strategic insight into prioritization and down-selection of therapeutic indications for DNA-based vaccine programs at Inovio Pharmaceuticals. She also provided leadership for novel therapeutic vaccine target evaluation, discovery and design to support the robust product portfolio of therapeutics in solid tumors.

Jian started her career as a postdoctoral researcher at University of Pennsylvania where she created and established novel vaccine design strategy, design and developed multiple therapeutic DNA vaccines. She has authored over 80 peer-reviewed publications in the area of DNA-based immunotherapy. She is also a co-inventor of more than 60 patents to innovative vaccine and antibody claims and was selected as one of the “Top 20 Translational Researchers” for 2016 and 2018 by Nature Biotechnology.

Dr. Jian Yan received her Ph. D. in Molecular Biology and Genetics from Fudan University through a co-training program between Fudan University and Yale University.